Ovid Therapeutics
OVID
OVID
75 hedge funds and large institutions have $54.7M invested in Ovid Therapeutics in 2024 Q3 according to their latest regulatory filings, with 9 funds opening new positions, 32 increasing their positions, 15 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
75
Holders Change
+1
Holders Change %
+1.35%
% of All Funds
1.08%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.01%
New
9
Increased
32
Reduced
15
Closed
8
Calls
$47K
Puts
$13K
Net Calls
+$34K
Net Calls Change
+$19K
Top Buyers
| 1 |
UOC
UBS O'Connor
Chicago,
Illinois
|
+$401K |
| 2 |
BlackRock
New York
|
+$380K |
| 3 |
BNP Paribas Financial Markets
Paris,
France
|
+$254K |
| 4 |
Acadian Asset Management
Boston,
Massachusetts
|
+$215K |
| 5 |
GCP
GSA Capital Partners
London,
United Kingdom
|
+$166K |
Top Sellers
| 1 |
AG
Artal Group
Luxembourg
|
-$1.92M |
| 2 |
TA
TLS Advisors
Miami,
Florida
|
-$417K |
| 3 |
PM
Prosight Management
Dallas,
Texas
|
-$408K |
| 4 |
FWM
FFT Wealth Management
Philadelphia,
Pennsylvania
|
-$377K |
| 5 |
Dimensional Fund Advisors
Austin,
Texas
|
-$202K |
